Akbarialiabad H, Taghrir MH, Abdollahi A, Ghahramani N, Kumar M, Paydar S, et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49(6):1163–86.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Almas T, Malik J, Alsubai AK, Jawad Zaidi SM, Iqbal R, Khan K, et al. Post-acute COVID-19 syndrome and its prolonged effects: an updated systematic review. Ann Med Surg. 2022;80:103995.

Article  Google Scholar 

Altmann DM, Whettlock EM, Liu S, Arachchillage DJ, Boyton RJ. The immunology of long COVID. Nat Rev Immunol. 2023;2023:1–17.

Google Scholar 

Ancona G, Alagna L, Alteri C, Palomba E, Tonizzo A, Pastena A, et al. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID. Front Immunol. 2023;14:1080043.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Angelidi AM, Kokkinos A, Katechaki E, Ros E, Mantzoros CS. Mediterranean diet as a nutritional approach for COVID-19. Metabolism. 2021;114:154407.

Article  PubMed  CAS  Google Scholar 

Anjana NKN, Annie TT, Siba S, Meenu MS, Chintha S, Anish TSN. Manifestations and risk factors of post COVID syndrome among COVID-19 patients presented with minimal symptoms–a study from Kerala, India. J Fam Med Prim Care. 2021;10(11):4023.

Article  Google Scholar 

Anwar F, Altayb HN, Al-Abbasi FA, Al-Malki AL, Kamal MA, Kumar V. Antiviral effects of probiotic metabolites on COVID-19. J Biomol Struct Dyn. 2020;39(11):1.

Google Scholar 

Arneth BM. Gut–brain axis biochemical signalling from the gastrointestinal tract to the central nervous system: gut dysbiosis and altered brain function. Postgrad Med J. 2018;94(1114):446–52.

Article  PubMed  CAS  Google Scholar 

Baindara P, Chakraborty R, Holliday ZM, Mandal SM, Schrum AG. Oral probiotics in coronavirus disease 2019: connecting the gut–lung axis to viral pathogenesis, inflammation, secondary infection and clinical trials. New Microb New Infect. 2021;40:100837.

Article  CAS  Google Scholar 

Ballouz T, Menges D, Anagnostopoulos A, Domenghino A, Aschmann HE, Frei A, et al. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study. BMJ. 2023;381: e074425.

Article  PubMed  PubMed Central  Google Scholar 

Barrea L, Grant WB, Frias-Toral E, Vetrani C, Verde L, de Alteriis G, et al. Dietary recommendations for post-COVID-19 syndrome. Nutrients. 2022;14(6):1305.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bell ML, Catalfamo CJ, Farland LV, Ernst KC, Jacobs ET, Klimentidis YC, et al. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: results from the Arizona CoVHORT. PLoS ONE. 2021;16(8): e0254347.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bergamaschi L, Mescia F, Turner L, Hanson AL, Kotagiri P, Dunmore BJ, et al. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity. 2021;54(6):1257.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bicknell B, Liebert A, Borody T, Herkes G, McLachlan C, Kiat H. Neurodegenerative and neurodevelopmental diseases and the gut-brain axis: the potential of therapeutic targeting of the microbiome. Int J Mol Sci. 2023;24(11):24.

Article  Google Scholar 

Bostick JW, Schonhoff AM, Mazmanian SK. Gut microbiome-mediated regulation of neuroinflammation. Curr Opin Immunol. 2022;76: 102177.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Tóth M, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014;6(263):263158–263158.

Article  Google Scholar 

Breton J, Galmiche M, Déchelotte P. Dysbiotic gut bacteria in obesity: an overview of the metabolic mechanisms and therapeutic perspectives of next-generation probiotics. Microorganisms. 2022;10(2):452.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Burgueno JF, Reich A, Hazime H, Quintero MA, Fernandez I, Fritsch J, et al. Expression of SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in the gut of patients with IBD. Inflamm Bowel Dis. 2020;26(6):797.

Article  PubMed  PubMed Central  Google Scholar 

Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–5.

Article  PubMed  PubMed Central  Google Scholar 

Carvalho T, Krammer F, Iwasaki A. The first 12 months of COVID-19: a timeline of immunological insights. Nat Rev Immunol. 2021;21(4):245–56.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen Y, Gu S, Chen Y, Lu H, Shi D, Guo J, et al. Six-month follow-up of gut microbiota richness in patients with COVID-19. Gut. 2022;71(1):222–5.

Article  PubMed  Google Scholar 

Cheng X, Zhang Y, Li Y, Wu Q, Wu J, Park SK, et al. Meta-analysis of 16S rRNA microbial data identified alterations of the gut microbiota in COVID-19 patients during the acute and recovery phases. BMC Microbiol. 2022;22(1):1–13.

Article  Google Scholar 

Cheong K-L, Chen S, Teng B, Veeraperumal S, Zhong S, Tan K. Oligosaccharides as potential regulators of gut microbiota and intestinal health in post-COVID-19 management. Pharmaceuticals. 2023;16(6):860.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Choudhury A, Tariq R, Jena A, Vesely EK, Singh S, Khanna S, et al. Gastrointestinal manifestations of long COVID: a systematic review and meta-analysis. Therap Adv Gastroenterol. 2022;15:17562848221118404.

Article  PubMed  PubMed Central  Google Scholar 

Ciarambino T, Para O, Giordano M. Immune system and COVID-19 by sex differences and age. Womens Health. 2021;17:17455065211022262.

CAS  Google Scholar 

Coles MJ, Masood M, Crowley MM, Hudgi A, Okereke C, Klein J. It ain’t over ’til it’s over: SARS CoV-2 and post-infectious gastrointestinal dysmotility. Dig Dis Sci. 2022;67(12):5407.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cui G-Y, Rao B-C, Zeng Z-H, Wang X-M, Ren T, Wang H-Y, et al. Characterization of oral and gut microbiome and plasma metabolomics in COVID-19 patients after 1-year follow-up. Mil Med Res. 2022;9(1):32.

PubMed  PubMed Central  CAS  Google Scholar 

Daitch V, Yelin D, Awwad M, Guaraldi G, Milić J, Mussini C, et al. Characteristics of long-COVID among older adults: a cross-sectional study. Int J Infect Dis. 2022;125:287–93.

Article  PubMed  Google Scholar 

Dashraath P, Wong JLJ, Lim MXK, Lim LM, Li S, Biswas A, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstetr Gynecol. 2020;222(6):521.

Article  CAS  Google Scholar 

Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ, et al. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods. 2019;8(3):92.

Article  PubMed  PubMed Central  CAS  Google Scholar 

de Oliveira AP, Lopes ALF, Pacheco G, de Nolêto IR, Nicolau LAD, Medeiros JV. Premises among SARS-CoV-2, dysbiosis and diarrhea: walking through the ACE2/mTOR/autophagy route. Med Hypotheses. 2020;144: 110243.

Article  PubMed  PubMed Central  Google Scholar 

Desgranges F, Tadini E, Munting A, Regina J, Filippidis P, Viala B, et al. Post-COVID-19 syndrome in outpatients: a cohort study. J Gen Intern Med. 2022;37(8):1943.

Article  PubMed  PubMed Central  Google Scholar 

Devaux CA, Lagier JC, Raoult D. New insights into the physiopathology of COVID-19: SARS-CoV-2-associated gastrointestinal illness. Front Med. 2021;8:640073.

Article